BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272


SEARCH JOBS




Industry
Healthcare

Segment
Pharmaceuticals





 Company News
Astellas Pharma Inc. (ALPMY) Details Pipeline Progress At R&D Meeting 7/11/2014 8:10:48 AM
Astellas Pharma Inc. (ALPMY) Details Pipeline Progress At R&D Meeting 7/11/2014 6:48:00 AM
Basilea Pharmaceutica (BSLN.SW)'s Partner Astellas Pharma Inc. (ALPMY) Submits Isavuconazole U.S. NDA For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis 7/9/2014 2:01:03 PM
Astellas Pharma Inc. (ALPMY) Submits U.S. New Drug Application For Isavuconazole For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis 7/9/2014 10:26:22 AM
Astellas Pharma Inc. (ALPMY) Returns To "Give Kids The World" And Expands Partnership With Starlight Children's Foundation To Brighten The Lives Of Young Patients & Their Families 6/11/2014 10:01:54 AM
Astellas Pharma Inc. (ALPMY) Release: The New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer 6/2/2014 10:14:25 AM
Astellas Pharma Inc. (ALPMY) And Medivation, Inc. (MDVN) Receive Priority Review From FDA For XTANDI® (Enzalutamide) Capsules In Chemotherapy-Naive Advanced Prostate Cancer 5/6/2014 9:34:58 AM
Astellas Pharma Inc. (ALPMY) Makes $7.3 Million Deal With U.S. Department Of Justice 4/17/2014 6:34:32 AM
Astellas Pharma Inc. (ALPMY) Announces Marketing Approval In Japan For XTANDI® (Enzalutamide) Capsules, An Advanced Prostate Cancer Treatment 3/25/2014 6:47:44 AM
Astellas Pharma Inc. (ALPMY) And Daiichi Sankyo, Inc. (4568.t) Form Compound Library Sharing Partnership 3/20/2014 10:13:49 AM
12345678910...